GGrantIndex
Sort

17,054 grants matching genome editing

Investigating the roles of oncogenic extrachromosomal circular DNAs in cancer

$566,683
Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Investigating the roles of oncogenic extrachromosomal circular DNAs in cancer

$566,683
Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Human iPSC Model for Elucidating Crosstalk Signaling and Secretomes

$566,573
Joseph C Wu · Stanford University · R01 · FY2021 · HL

Genetic Studies of Sarcomere-based Cardiac Diseases

$566,562
Xiaolei Xu · Mayo Clinic Rochester · R01 · FY2022 · HL

Project 2: Genes required for dendritic cell responses to pathogens and T cells

$566,542
Nir Hacohen · Harvard Medical School · U19 · FY2017 · AI

Xenopus models of human disease by targeted genome editing

$566,476
Marko E Horb · Marine Biological Laboratory · R01 · FY2019 · HD

Chromosome 17q21, allergic inflammation, and remodeling

$566,385
David H Broide · University Of California, San Diego · R01 · FY2021 · AI

Proteome-wide base editor screens to assess phosphorylation site functionality in immunosenescence

$566,215
Sam Anthony Myers · La Jolla Institute For Immunology · R01 · FY2025 · CA

Rapid ex vivo biosensor cultures to assess dependencies in gastroesophageal cancer

$566,213
Jesse Samuel Boehm · Broad Institute, Inc. · R01 · FY2021 · CA

Rapid ex vivo biosensor cultures to assess dependencies in gastroesophageal cancer

$566,213
Jesse Samuel Boehm · Broad Institute, Inc. · R01 · FY2020 · CA

Enhancing the C. elegans animal resource through genome editing

$566,208
Ann E. Rougvie · University Of Minnesota · R24 · FY2018 · OD

Cis Regulatory Elements and Systemic Lupus Erythematosus

$566,178
Joseph E Craft · Yale University · R01 · FY2019 · AR

Establishing and reversing the functional consequences of Titin truncation mutations

$566,102
John Travis Hinson · University Of Connecticut Sch Of Med/Dnt · R01 · FY2022 · HL

Defining the functional interface between the ER and flaviviruses

$566,093
Sara Cherry · University Of Pennsylvania · R01 · FY2018 · AI

Telomere dysfunction driven molecular outputs in the cardiac unit

$566,000
Aditi U Gurkar · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · ES

Telomere dysfunction driven molecular outputs in the cardiac unit

$566,000
Aditi U Gurkar · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · ES

Contribution of the NOD/RIPK2 signaling pathway to osteoarthritis susceptibility

$565,922
Michael J Jurynec · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AR

Lysosomal Diseases

$565,852
Rosa Puertollano-Moro · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

Nonviral delivery of CRISPR-Cas9 into hepatocytes combined with APAP selection for treatment of Familial Hypercholesterolemia

$565,787
Renee Nicole Cottle · Clemson University · R56 · FY2023 · HL

Epigenetic dysregulation in diabetic enteric neuropathy

$565,705
Tamas Ordog · Mayo Clinic Rochester · R01 · FY2022 · DK

"Off-the-Shelf" iPSC-Derived Regulatory T Cell Immunotherapeutics

$565,672
Bruce R. Blazar · University Of Minnesota · P01 · FY2024 · CA

Improving response durability after CAR T cell therapy for multiple myeloma

$565,591
Michael C. Milone · University Of Pennsylvania · P01 · FY2024 · CA

Characterization and modeling of m6A RNA methylation in cancer

$565,529
Han Liang · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Molecular mechanism of the visual disorders caused by G90D and G90V rhodopsin mutations

$565,284
Vladimir Jivkov Kefalov · University Of California-Irvine · R01 · FY2025 · EY

Project 1. Gene Variants and Their Interactions Defining Human NTD Risk

$565,269
Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · P01 · FY2019 · HD